{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:58:59Z","timestamp":1780923539547,"version":"3.54.1"},"reference-count":66,"publisher":"Impact Journals, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2017,4,28]]},"DOI":"10.18632\/aging.101230","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T15:12:21Z","timestamp":1493392341000},"page":"1326-1340","source":"Crossref","is-referenced-by-count":40,"title":["BMP2 promotes proliferation and invasion of nasopharyngeal carcinoma cells via mTORC1 pathway"],"prefix":"10.18632","volume":"9","author":[{"given":"Meng-He","family":"Wang","sequence":"first","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangzhou, 510060, China"},{"name":"Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Min","family":"Zhou","sequence":"additional","affiliation":[{"name":"Zhoukou Hospital of Traditional Chinese Medicine, Zhoukou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Yin","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangzhou, 510060, China"},{"name":"Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Shi","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangzhou, 510060, China"},{"name":"Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-Wen","family":"Xiao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangzhou, 510060, China"},{"name":"Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Si","family":"Zeng","sequence":"additional","affiliation":[{"name":"Cancer Center of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Zi","family":"Yang","sequence":"additional","affiliation":[{"name":"Cancer Center of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.F. Steven","family":"Zheng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangzhou, 510060, China"},{"name":"Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Yun","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangzhou, 510060, China"},{"name":"Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Juan","family":"Mai","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangzhou, 510060, China"},{"name":"Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,4,28]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/S0140-6736(05)66698-6","article-title":"Nasopharyngeal carcinoma.","volume":"36","author":"Sham","year":"2005","journal-title":"Lancet"},{"key":"2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.5732\/cjc.010.10377","article-title":"The prevalence and prevention of nasopharyngeal carcinoma in China.","volume":"3","author":"Qian","year":"2011","journal-title":"Chin J Cancer"},{"key":"3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.semcancer.2012.01.012","article-title":"Familial and large-scale case-control studies identify genes associated with nasopharyngeal carcinoma.","volume":"2","author":"Zeng","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-2407-12-98","article-title":"Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence.","volume":"1","author":"Lu","year":"2012","journal-title":"BMC Cancer"},{"key":"5","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.ejca.2010.04.004","article-title":"Nasopharyngeal carcinoma: the next challenges.","volume":"4","author":"Chan","year":"2010","journal-title":"Eur J Cancer"},{"key":"6","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","article-title":"Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.","volume":"11","author":"Lu","year":"2014","journal-title":"Radiother Oncol"},{"key":"7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.radonc.2014.05.005","article-title":"Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study.","volume":"11","author":"Hu","year":"2014","journal-title":"Radiother Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.clon.2012.10.006","article-title":"Nasopharyngeal carcinoma: a retrospective review of demographics, treatment and patient outcome in a single centre.","volume":"2","author":"Lee","year":"2013","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.abb.2014.07.011","article-title":"Bone Morphogenetic Proteins: structure, biological function and therapeutic applications.","volume":"56","author":"Granjeiro","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/08977190412331279890","article-title":"Bone morphogenetic proteins.","volume":"2","author":"Mundy","year":"2004","journal-title":"Growth Factors"},{"key":"11","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0959-437X(96)80064-5","article-title":"Bone morphogenetic proteins in development.","volume":"6","author":"Hogan","year":"1996","journal-title":"Curr Opin Genet Dev"},{"key":"12","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2174\/15680096113136660101","article-title":"Regulation of EMT by Notch signaling pathway in tumor progression.","volume":"1","author":"Wang","year":"2013","journal-title":"Curr Cancer Drug Targets"},{"key":"13","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.febslet.2012.04.030","article-title":"BMP signaling in vascular diseases.","volume":"58","author":"ten Dijke","year":"2012","journal-title":"FEBS Lett"},{"key":"14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1227\/01.NEU.0000363722.42097.C2","article-title":"Bone morphogenetic proteins and cancer: review of the literature.","volume":"6","author":"Park","year":"2010","journal-title":"Neurosurgery"},{"key":"15","doi-asserted-by":"publisher","first-page":"R123","DOI":"10.1677\/ERC-09-0273","article-title":"Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis?","volume":"1","author":"Kallioniemi","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/pin.12067","article-title":"Bi-directional roles of bone morphogenetic proteins in cancer: another molecular Jekyll and Hyde?","volume":"6","author":"Miyazono","year":"2013","journal-title":"Pathol Int"},{"key":"17","doi-asserted-by":"publisher","first-page":"37499","DOI":"10.1038\/srep37499","article-title":"Promotive effects of bone morphogenetic protein 2 on angiogenesis in hepatocarcinoma via multiple signal pathways.","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"key":"18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/cgt.2010.55","article-title":"Effects of siRNA-targeting BMP-2 on the abilities of migration and invasion of human liver cancer SMMC7721 cells and its mechanism.","volume":"1","author":"Zhang","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1746-1596-9-123","article-title":"Silencing BMP-2 expression inhibits A549 and H460 cell proliferation and migration.","volume":"9","author":"Zhang","year":"2014","journal-title":"Diagn Pathol"},{"key":"20","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.7314\/APJCP.2013.14.9.5293","article-title":"Serum BMP-2 up-regulation as an indicator of poor survival in advanced non-small cell lung cancer patients.","volume":"1","author":"Ma","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"21","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s12032-011-9852-9","article-title":"The serum bone morphogenetic protein-2 level in non-small-cell lung cancer patients.","volume":"2","author":"Kim","year":"2012","journal-title":"Med Oncol"},{"key":"22","doi-asserted-by":"publisher","first-page":"37335","DOI":"10.1074\/jbc.M111.256156","article-title":"Lung tumor-associated osteoblast-derived bone morphogenetic protein-2 increased epithelial-to-mesenchymal transition of cancer by Runx2\/Snail signaling pathway.","volume":"28","author":"Kuo","year":"2011","journal-title":"J Biol Chem"},{"key":"23","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1007\/s12032-009-9358-x","article-title":"Bone morphogenetic protein-2 levels are elevated in the patients with gastric cancer and correlate with disease progression.","volume":"2","author":"Oh","year":"2010","journal-title":"Med Oncol"},{"key":"24","first-page":"1465","article-title":"Expression of bone morphogenetic protein 2 in breast cancer cells inhibits hypoxic cell death.","volume":"2","author":"Harris","year":"2005","journal-title":"Int J Oncol"},{"key":"25","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1038\/onc.2008.232","article-title":"Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.","volume":"2","author":"Imamura","year":"2008","journal-title":"Oncogene"},{"key":"26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12032-015-0547-5","article-title":"C23 protein meditates bone morphogenetic protein-2-mediated EMT via up-regulation of Erk1\/2 and Akt in gastric cancer.","volume":"3","author":"Zhang","year":"2015","journal-title":"Med Oncol"},{"key":"27","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s13277-014-2901-1","article-title":"Bone morphogenetic protein 2 mediates epithelial-mesenchymal transition via AKT and ERK signaling pathways in gastric cancer.","volume":"3","author":"Shi","year":"2015","journal-title":"Tumour Biol"},{"key":"28","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.yexcr.2011.04.006","article-title":"Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K\/AKT, MAPK, the NF-\u03baB pathway, and MMP-9 expression.","volume":"31","author":"Yoo","year":"2011","journal-title":"Exp Cell Res"},{"key":"29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12935-016-0355-9","article-title":"Bone morphogenetic protein 2 (BMP2) induces growth suppression and enhances chemosensitivity of human colon cancer cells.","volume":"1","author":"Alajez","year":"2016","journal-title":"Cancer Cell Int"},{"key":"30","doi-asserted-by":"publisher","first-page":"9475","DOI":"10.1007\/s13277-015-3681-y","article-title":"BMP-2 induces motility and invasiveness by promoting colon cancer stemness through STAT3 activation.","volume":"3","author":"Min","year":"2015","journal-title":"Tumour Biol"},{"key":"31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.anndiagpath.2012.05.008","article-title":"Expression of bone-morphogenetic protein 2 and tumor necrosis factor \u03b1 correlates with bone metastases in bladder urothelial carcinoma.","volume":"1","author":"Zhu","year":"2013","journal-title":"Ann Diagn Pathol"},{"key":"32","doi-asserted-by":"publisher","first-page":"927","DOI":"10.7314\/APJCP.2016.17.3.927","article-title":"Recombinant Human Bone Morphogenetic Protein-2 in Development and Progression of Oral Squamous Cell Carcinoma.","volume":"1","author":"Bassit","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1349-7006.2009.01356.x","article-title":"Independent and cooperative roles of tumor necrosis factor-alpha, nuclear factor-kappaB, and bone morphogenetic protein-2 in regulation of metastasis and osteomimicry of prostate cancer cells and differentiation and mineralization of MC3T3-E1 osteoblast-like cells.","volume":"10","author":"Abdel-Mageed","year":"2010","journal-title":"Cancer Sci"},{"key":"34","doi-asserted-by":"publisher","first-page":"e1957","DOI":"10.7717\/peerj.1957","article-title":"BMP2\/BMPR1A is linked to tumour progression in dedifferentiated liposarcomas.","volume":"4","author":"Cassidy","year":"2016","journal-title":"PeerJ"},{"key":"35","first-page":"323","article-title":"The role of bone morphogenetic proteins in ovarian function.","volume":"6","author":"Otsuka","year":"2003","journal-title":"Reprod Suppl"},{"key":"36","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus.","volume":"11","author":"Massagu\u00e9","year":"2003","journal-title":"Cell"},{"key":"37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.4161\/cbt.11.5.14372","article-title":"BMP-2 inhibits the tumorigenicity of cancer stem cells in human osteosarcoma OS99-1 cell line.","volume":"1","author":"Lin","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"38","first-page":"1013","article-title":"Bone morphogenetic protein 2 inhibits the proliferation and growth of human colorectal cancer cells.","volume":"3","author":"Liu","year":"2014","journal-title":"Oncol Rep"},{"key":"39","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1007\/s13277-014-1673-y","article-title":"Bone morphogenetic protein 2 inhibits hepatocellular carcinoma growth and migration through downregulation of the PI3K\/AKT pathway.","volume":"3","author":"Chang","year":"2014","journal-title":"Tumour Biol"},{"key":"40","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1242\/jcs.095299","article-title":"TGF-\u03b2-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion.","volume":"12","author":"Derynck","year":"2012","journal-title":"J Cell Sci"},{"key":"41","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease.","volume":"14","author":"Sabatini","year":"2012","journal-title":"Cell"},{"key":"42","first-page":"eg4","article-title":"Focus issue: TOR signaling, a tale of two complexes.","volume":"5","author":"Gough","year":"2012","journal-title":"Sci Signal"},{"key":"43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.molmed.2007.08.001","article-title":"Targeting the mTOR signaling network in cancer.","volume":"1","author":"Abraham","year":"2007","journal-title":"Trends Mol Med"},{"key":"44","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.3390\/ijms13021886","article-title":"The mTOR signalling pathway in human cancer.","volume":"1","author":"Soares","year":"2012","journal-title":"Int J Mol Sci"},{"key":"45","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1158\/0008-5472.CAN-10-4058","article-title":"mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.","volume":"7","author":"Evers","year":"2011","journal-title":"Cancer Res"},{"key":"46","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s13277-011-0272-4","article-title":"Activation of AKT is associated with metastasis of nasopharyngeal carcinoma.","volume":"3","author":"Guan","year":"2012","journal-title":"Tumour Biol"},{"key":"47","doi-asserted-by":"publisher","first-page":"e106098","DOI":"10.1371\/journal.pone.0106098","article-title":"Activation of Akt\/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma.","volume":"9","author":"Fan","year":"2014","journal-title":"PLoS One"},{"key":"48","doi-asserted-by":"publisher","first-page":"37576","DOI":"10.1038\/srep37576","article-title":"Genetic variations in the PI3K-PTEN-AKT-mTOR pathway are associated with distant metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.","volume":"6","author":"Yuan","year":"2016","journal-title":"Sci Rep"},{"key":"49","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0092-8674(00)81696-7","article-title":"Smads: transcriptional activators of TGF-beta responses.","volume":"9","author":"Feng","year":"1998","journal-title":"Cell"},{"key":"50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2005.06.017","article-title":"The BMP signaling and in vivo bone formation.","volume":"35","author":"Chen","year":"2005","journal-title":"Gene"},{"key":"51","doi-asserted-by":"publisher","first-page":"31985","DOI":"10.1074\/jbc.M110.123612","article-title":"p38 regulates expression of osteoblast-specific genes by phosphorylation of osterix.","volume":"28","author":"Ventura","year":"2010","journal-title":"J Biol Chem"},{"key":"52","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1089\/scd.2012.0226","article-title":"Activated NF-\u03baB in bone marrow mesenchymal stem cells from systemic lupus erythematosus patients inhibits osteogenic differentiation through downregulating Smad signaling.","volume":"2","author":"Sun","year":"2013","journal-title":"Stem Cells Dev"},{"key":"53","doi-asserted-by":"publisher","first-page":"33361","DOI":"10.1074\/jbc.M205053200","article-title":"Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine\/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription.","volume":"27","author":"Choudhury","year":"2002","journal-title":"J Biol Chem"},{"key":"54","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1158\/1541-7786.MCR-05-0124","article-title":"Bone morphogenetic protein-2-induced transformation involves the activation of mammalian target of rapamycin.","volume":"3","author":"Langenfeld","year":"2005","journal-title":"Mol Cancer Res"},{"key":"55","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/jcp.21568","article-title":"BMP-2 increases migration of human chondrosarcoma cells via PI3K\/Akt pathway.","volume":"21","author":"Tang","year":"2008","journal-title":"J Cell Physiol"},{"key":"56","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12253-010-9307-1","article-title":"Activation of the PI3K\/Akt pathway mediates bone morphogenetic protein 2-induced invasion of pancreatic cancer cells Panc-1.","volume":"1","author":"Sun","year":"2011","journal-title":"Pathol Oncol Res"},{"key":"57","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yexcr.2009.10.010","article-title":"BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)\/Akt pathway.","volume":"31","author":"Yoo","year":"2010","journal-title":"Exp Cell Res"},{"key":"58","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1259\/0007-1285-63-746-108","article-title":"Nasopharyngeal carcinoma: the significance of neck node involvement in relation to the pattern of distant failure.","volume":"6","author":"Choi","year":"1990","journal-title":"Br J Radiol"},{"key":"59","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10549-006-9362-1","article-title":"A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7.","volume":"10","author":"Kallioniemi","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"60","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1083\/jcb.113.3.681","article-title":"Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro.","volume":"11","author":"Yoshiki","year":"1991","journal-title":"J Cell Biol"},{"key":"61","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/mrd.1080320212","article-title":"The bone morphogenetic protein family and osteogenesis.","volume":"3","author":"Wozney","year":"1992","journal-title":"Mol Reprod Dev"},{"key":"62","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.anndiagpath.2012.11.004","article-title":"Med19 promotes bone metastasis and invasiveness of bladder urothelial carcinoma via bone morphogenetic protein 2.","volume":"1","author":"Jiang","year":"2013","journal-title":"Ann Diagn Pathol"},{"key":"63","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3332\/ecancer.2017.715","article-title":"Bone metastasis risk factors in breast cancer.","volume":"1","author":"Costa","year":"2017","journal-title":"Ecancermedicalscience"},{"key":"64","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/pros.10193","article-title":"Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer.","volume":"5","author":"Yamanaka","year":"2003","journal-title":"Prostate"},{"key":"65","doi-asserted-by":"crossref","first-page":"13634","DOI":"10.18632\/oncotarget.7215","article-title":"Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN\/AKT\/mTOR signal pathway.","volume":"7","author":"Mai","year":"2016","journal-title":"Oncotarget"},{"key":"66","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.18632\/aging.100980","article-title":"Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma.","volume":"8","author":"Wang","year":"2016","journal-title":"Aging (Albany NY)"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.101230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T16:39:54Z","timestamp":1599064794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.101230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,28]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4,30]]}},"alternative-id":["101230","28455969"],"URL":"https:\/\/doi.org\/10.18632\/aging.101230","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,28]]}}}